Buprenorphine STADA transdermal patch

Buprenorphine STADA is a pharmaceutical product used for managing chronic pain. It is a transdermal patch containing buprenorphine, which is released gradually through the skin over several days. The STADA brand is a well-established name in the pharmaceutical industry, particularly known for its extensive range of generic and specialty medications.

Manufacturing of STADA products is primarily centered in Germany, where the company originates, but the group maintains a global supply chain with production facilities and partners across Europe and Asia to meet market demands. The brand is under the ownership of STADA Arzneimittel AG, which has transitioned from a traditional publicly traded company to being owned by private equity firms, primarily Bain Capital and Cinven, as of the current market structure heading into 2026.